Dr. Maria Prencipe was awarded her Degree in Biological Sciences in 1999 followed by a Master in Biochemistry and Molecular Biology in 2001 from L'Aquila University, Italy. After 3 years as a research assistant in the research hospital "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy, she moved to Ireland where she was awarded her PhD in Cancer Biology from University College Dublin, studying the mechanisms of resistance to taxane treatment in breast and ovarian cancer. As a postdoctoral fellow within Molecular Therapeutic for Cancer Ireland (MTCI) research cluster, she studied the molecular mechanisms of resistance to advanced prostate cancer treatments, identifying novel transcription factors as potential new therapies for advanced prostate cancer. She was awarded an Irish Cancer Society research fellowship in 2012 to carry on her work on transcription factors' role in prostate cancer which she expanded as part of the Fast-Path Marie Curie FP7 People work programme, Industry-Academia Partnerships and Pathways (IAPP), spending one year in OncoMark Ltd. Dr. Prencipe's work has resulted in a number of important publications and prizes such as the St. Luke's Young Investigator award in 2014.
- ItalianCan read, write, speak and understand